Xtx Topco LTD Iovance Biotherapeutics, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 40,136 shares of IOVA stock, worth $87,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,136
Previous 181,832
77.93%
Holding current value
$87,496
Previous $605,000
88.6%
% of portfolio
0.0%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding IOVA
# of Institutions
288Shares Held
234MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$63.1 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$54.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$46.3 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$25.8 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$21.6 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $344M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...